bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.02.02.703240

DSF signalling integrates c-di-GMP and σ54 pathways with metabolic reprogramming to control Stenotrophomonas maltophilia pathogenicity and antibiotic resistance

Abstract

Stenotrophomonas maltophilia is an opportunistic, multidrug-resistant pathogen whose pathogenicity is mainly driven by biofilm formation, extracellular enzyme production, surface adhesins and motility. In addition, a diffusible signal factor (DSF)-mediated quorum sensing (QS) system encoded by the rpf gene cluster coordinates collective behaviours and contributes to pathogenicity. While DSF signalling has been extensively studied in plant-pathogenic xanthomonads, its integration with transcriptional and metabolic regulation in human pathogens remains poorly defined. Here, we investigate how the DSF/Rpf system shapes virulence and adaptation in S. maltophilia by modulating downstream regulatory and metabolic pathways. Cell density-dependent activation of the RpfC-RpfG two-component system reduces intracellular c-di-GMP levels, promoting a growth phase-dependent switch between biofilm formation and motile lifestyle. This transition requires the global transcriptional regulator Clp, which functions as a transcriptional activator when unbound to c-di-GMP. Clp controls genes involved in motility, adhesion, and the alternative sigma factor {sigma} RpoN2, which inversely regulates flagellar motility and type IV pilus-mediated adhesion. Transcriptomic profiling uncovered additional DSF-dependent regulatory circuits linking quorum sensing to metabolism and antibiotic resistance. Notably, at the onset of stationary phase, the {sigma} paralog RpoN1 acts together with RpfF and RpfB to fine-tune DSF production through fatty acid and central carbon metabolism, coupling QS output to cellular metabolic state. This metabolic control constrains DSF output and impacts colistin susceptibility, highlighting clinically relevant consequences of DSF homeostasis. Together, these findings define a species-specific DSF regulatory architecture in S. maltophilia that integrates quorum sensing, second-messenger signalling, transcriptional regulation, and metabolic reprogramming to promote survival and pathogenicity. Author SummaryStenotrophomonas maltophilia is a bacterial pathogen that causes infections, particularly in hospitalized and immunocompromised patients. Its clinical impact is driven by intrinsic multidrug resistance and the ability to switch between a free-swimming state and a surface-attached biofilm state. Biofilms protect bacteria from antibiotics and the immune system, making infections persistent, while motility promotes spread and colonization. Understanding how S. maltophilia controls this balance is critical for combating infection. Like many bacteria, S. maltophilia uses chemical communication, known as quorum sensing, to sense population density and coordinate behaviours linked to virulence and survival. This system is based on the autoinducer DSF, allowing bacteria to decide when to move, attach, or alter metabolism. In this work, we show that DSF-based quorum sensing activates a regulatory cascade that modulates levels of the signalling molecule c-di-GMP, triggering a switch between biofilm formation and motility. This switch relies on global regulators that control genes involved in movement, adhesion, metabolism, and antibiotic resistance. We also uncover a metabolic feedback mechanism that fine-tunes DSF concentration, impacting bacteria state and antibiotic susceptibility. These findings reveal how bacterial communication, metabolism, and pathogenic behaviour are linked in S. maltophilia, highlighting opportunities for antimicrobial intervention.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bravo, M., Gomez, A.-C., Conchillo-Sole, O., Garcia-Navarro, A., Pons, J. L., Daura, X., Gibert, I., Yero, D.. 2026-02-03. DSF signalling integrates c-di-GMP and σ54 pathways with metabolic reprogramming to control Stenotrophomonas maltophilia pathogenicity and antibiotic resistance. https://doi.org/10.64898/2026.02.02.703240

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗